TMEM85 activators are a class of chemical compounds that interact with a specific type of transmembrane protein known as TMEM85. The nomenclature TMEM85 comes from "transmembrane protein 85", indicating that it is the 85th protein in this broad and diverse family of proteins cataloged within the human genome. Transmembrane proteins like TMEM85 span the lipid bilayer of the cell membrane, serving as conduits for communication between the intracellular and extracellular environments, participating in various cellular processes. The activators of TMEM85 are distinct in their ability to modulate the function of this particular protein, typically by binding to it in a manner that alters its conformation or its interaction with other molecules within the cell membrane or within the cell itself.
The molecular mechanisms by which TMEM85 activators exert their effects can be complex and multifaceted. These activators may induce a conformational change in the TMEM85 protein that can affect the protein's stability, its association with other cellular components, or its overall activity level. The structure-activity relationship (SAR) is a critical aspect of understanding how these activators work, as small changes to the chemical structure of an activator can lead to significant differences in how it interacts with TMEM85. The study of TMEM85 and its activators involves a multidisciplinary approach, encompassing biochemistry, molecular biology, and structural biology to elucidate the precise interactions at play. Understanding the precise biochemistry of how TMEM85 activators work can provide insights into the fundamental processes of cellular function and the intricate dance of proteins and molecules that sustain cellular life.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing intracellular cAMP levels. This can enhance TMEM85 activity through cAMP-dependent protein kinase (PKA) signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, leading to increased cAMP and cGMP in cells, which may enhance TMEM85 activity by preventing the breakdown of cAMP, thereby supporting PKA signaling pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that directly activates PKA. Elevated PKA activity may enhance TMEM85 function by phosphorylating proteins that interact with or regulate TMEM85. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Br-cAMP is a cell-permeable analog of cAMP that can activate PKA. This can lead to enhanced TMEM85 function by stimulating PKA-dependent signaling pathways. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic non-selective beta-adrenergic receptor agonist that raises intracellular cAMP levels, potentially enhancing TMEM85 activity via PKA activation. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, through beta-adrenergic receptors, increases cAMP in cells, which may enhance TMEM85 activity by activating PKA and modulating signaling pathways linked to TMEM85. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is a selective PDE5 inhibitor, which can lead to increased cGMP levels and indirectly enhance cAMP, potentially enhancing TMEM85 activity through cGMP-dependent pathways. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 interacts with its G protein-coupled receptors to elevate cAMP levels, which could enhance TMEM85 activity by stimulating the PKA signaling cascade. | ||||||